Opportunistic Salpingectomy at the Time of Benign Laparoscopic Hysterectomy (SLH)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03921138 |
Recruitment Status :
Completed
First Posted : April 19, 2019
Last Update Posted : April 19, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Benign Laparoscopic Hysterectomy Systematic Salpingectomy | Other: Histopathologic tube anomalies |
Study Type : | Observational |
Actual Enrollment : | 100 participants |
Observational Model: | Case-Only |
Time Perspective: | Prospective |
Official Title: | Opportunistic Salpingectomy at the Time of Benign Laparoscopic Hysterectomy : Assessment of Possible Complications and Histopathological Tumor Protein 53 (p53)-Signatures |
Actual Study Start Date : | January 31, 2014 |
Actual Primary Completion Date : | January 31, 2016 |
Actual Study Completion Date : | January 31, 2016 |

Group/Cohort | Intervention/treatment |
---|---|
Benign laparoscopic hysterectomy
Patients who underwent benign laparoscopic hysterectomy with systematic salpingectomy
|
Other: Histopathologic tube anomalies
Assessment of prevalence of histopathologic tube anomalies (Serous Tubal Intraepithelial Carcinoma (STIC) or tumor protein 53 (p53) lesion) |
- Histopathologic tube anomalies [ Time Frame: day 1 of surgery ]Prevalence of histopathologic tube anomalies (Serous Tubal Intraepithelial Carcinoma STIC or tumor protein 53 (p53) lesion)

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- patients who underwent benign laparoscopic hysterectomy with systematic salpingectomy
Exclusion Criteria:
- Hysterectomy in a context of gynecologic cancer
- Hysterectomy not carried out using laparoscopy
- Fimbriated end missing or damaged or impossible for pathologist to analyze

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03921138
Principal Investigator: | Gautier Chene, PhD | Hospices Civils de Lyon (Hôpital Femme Mère Enfant) |
Responsible Party: | Hospices Civils de Lyon |
ClinicalTrials.gov Identifier: | NCT03921138 |
Other Study ID Numbers: |
SLH |
First Posted: | April 19, 2019 Key Record Dates |
Last Update Posted: | April 19, 2019 |
Last Verified: | April 2019 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |